Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Department of the Army intends to award a sole source contract to Boston Scientific for Yttrium 90 microspheres, a liver cancer therapy. This product is FDA approved and will be used at Brooke Army Medical Center. The award is expected by September 30, 2025.
Notice of Intent to Award Sole Source.
The Medical Readiness Contracting Office-West, JBSA - Fort Sam Houston, Texas intends to award a Firm- Fixed-Price sole source contract to Boston Scientific under the authority of Federal Acquisition Regulation (FAR) 13.501(a)(1)(ii), sole source, for Yttrium 90 which is a liver cancer therapy that consists of millions of small glass microspheres containing radioactive Yttrium 90 and who has the only Food and Drug Administration (FDA) approved treatment for Primary liver cancer, for The Interventional Department of Radiology, at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, TX The applicable NAICS code for this requirement is 325412, Surgical Appliance and Supplies Manufacturing. The Small Business Size Standard is 1,300 employees. Award will be made on or before 30 September 2025. The solicitation number is W81K00-25-Q-A232 and is generated for the purposes of posting this notice. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE PROPOSALS A determination by the Government not to compete the interim purchase order based upon responses to this notice is solely within the discretion of the Government.
YTTRIUM-90 MICROSPHERES is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.